AMENDMENT TO STOCK PURCHASE AGREEMENT AND LETTER OF INVESTMENT INTENTStock Purchase Agreement • July 13th, 2021 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledJuly 13th, 2021 Company Industry JurisdictionTHIS AMENDMENT TO STOCK PURCHASE AGREEMENT AND LETTER OF INVESTMENT INTENT (this “Amendment”) is made and entered into effective as of July 8, 2021, by and between Navidea Biopharmaceuticals, Inc., a Delaware corporation (the “Company”) and Keystone Capital Partners LLC, a Delaware limited liability company (the “Investor”).